finance.yahoo.comNuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference10 months ago
finance.yahoo.comNew Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy11 months ago
finance.yahoo.comNuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules11 months ago
finance.yahoo.comNasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions12 months ago
finance.yahoo.comNuwellis Announces Pricing of $2.0 Million OfferingPriced At-The-Market Under Nasdaq Rules12 months ago
finance.yahoo.comNuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 202412 months ago
finance.yahoo.comSeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partnerabout 1 year ago
finance.yahoo.comNew Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conferenceabout 1 year ago